Total Payments
$13,128
2024 Payments
$1,308
Companies
61
Transactions
871
Medicare Patients
2,276
Medicare Billing
$224,252
Payment Breakdown by Category
Food & Beverage$13,087 (99.7%)
Education$41.04 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,087 | 868 | 99.7% |
| Education | $41.04 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,579 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,240 | 77 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $959.08 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $922.63 | 66 | $0 (2024) |
| Merck Sharp & Dohme LLC | $871.48 | 68 | $0 (2023) |
| PFIZER INC. | $862.48 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $712.52 | 38 | $0 (2024) |
| Amgen Inc. | $693.47 | 46 | $0 (2024) |
| ABBVIE INC. | $641.36 | 41 | $0 (2024) |
| Lilly USA, LLC | $635.67 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,308 | 63 | Boehringer Ingelheim Pharmaceuticals, Inc. ($186.76) |
| 2023 | $1,799 | 107 | PFIZER INC. ($237.49) |
| 2022 | $1,769 | 105 | Novo Nordisk Inc ($196.17) |
| 2021 | $1,898 | 133 | AbbVie Inc. ($191.52) |
| 2020 | $1,667 | 117 | AstraZeneca Pharmaceuticals LP ($333.28) |
| 2019 | $1,510 | 112 | Novo Nordisk Inc ($298.36) |
| 2018 | $1,488 | 107 | Novo Nordisk Inc ($237.33) |
| 2017 | $1,688 | 127 | AstraZeneca Pharmaceuticals LP ($218.77) |
All Payment Transactions
871 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Inflammation | ||||||
| 11/27/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes Care | ||||||
| 10/30/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.72 | General |
| 10/17/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $124.65 | General |
| Category: DIABETES | ||||||
| 09/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Oncology | ||||||
| 09/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Diabetes Care | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardio-renal | ||||||
| 08/06/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Oncology | ||||||
| 07/22/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Vaccines | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Diabetes Care | ||||||
| 07/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 456 | 654 | $176,037 | $53,121 |
| 2022 | 9 | 501 | 696 | $183,060 | $56,104 |
| 2021 | 10 | 593 | 796 | $200,885 | $55,662 |
| 2020 | 12 | 726 | 1,017 | $246,389 | $59,366 |
Total Patients
2,276
Total Services
3,163
Medicare Billing
$224,252
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 426 | $137,598 | $33,186 | 24.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 37 | 37 | $14,689 | $10,131 | 69.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 58 | $5,220 | $4,162 | 79.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 56 | $3,360 | $1,653 | 49.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,500 | $1,524 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $5,450 | $1,374 | 25.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 37 | 37 | $2,220 | $1,092 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 241 | 430 | $138,890 | $35,486 | 25.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 56 | 56 | $5,040 | $3,802 | 75.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 57 | $12,426 | $3,674 | 29.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $5,161 | $3,626 | 70.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $7,458 | $2,809 | 37.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 20 | 20 | $4,080 | $2,649 | 64.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $3,480 | $1,654 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $4,785 | $1,570 | 32.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 29 | 29 | $1,740 | $832.59 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 276 | 463 | $149,549 | $36,816 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 85 | $18,530 | $4,688 | 25.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 60 | 60 | $5,400 | $3,907 | 72.4% |
| 90670 | Pneumococcal vaccine for injection into muscle | Office | 2021 | 15 | 15 | $6,435 | $3,542 | 55.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 26 | 26 | $5,304 | $3,244 | 61.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $7,500 | $1,502 | 20.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 65 | 65 | $3,900 | $1,071 | 27.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 40 | 40 | $2,400 | $655.80 | 27.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 14 | $1,022 | $121.44 | 11.9% |
About Dr. Ramesh Amara, MD
Dr. Ramesh Amara, MD is a Internal Medicine healthcare provider based in Frisco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104892959.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Amara, MD has received a total of $13,128 in payments from pharmaceutical and medical device companies, with $1,308 received in 2024. These payments were reported across 871 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,087).
As a Medicare-enrolled provider, Amara has provided services to 2,276 Medicare beneficiaries, totaling 3,163 services with total Medicare billing of $224,252. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Frisco, TX
- Active Since 02/23/2006
- Last Updated 02/28/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104892959
Products in Payments
- FARXIGA (Drug) $866.17
- JARDIANCE (Drug) $722.60
- XARELTO (Drug) $560.78
- JANUVIA (Drug) $446.05
- Vascepa (Drug) $414.31
- Ozempic (Drug) $411.17
- ELIQUIS (Drug) $359.02
- Rybelsus (Drug) $313.94
- TRELEGY ELLIPTA (Drug) $311.71
- Aimovig (Biological) $305.51
- SHINGRIX (Biological) $276.21
- SPRAVATO (Drug) $266.61
- Livalo (Drug) $252.94
- BELSOMRA (Drug) $239.24
- NURTEC ODT (Drug) $236.59
- Saxenda (Drug) $234.69
- Cologuard Collection Kit (Device) $234.55
- UBRELVY (Drug) $225.48
- Kerendia (Drug) $218.62
- FREESTYLE LIBRE 3 (Device) $211.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Frisco
Jasbir Dhawan, Md, MD
Internal Medicine — Payments: $320,303
Internal Medicine $320,303
Jason Riehs, Md, MD
Internal Medicine — Payments: $201,897
Internal Medicine $201,897
Dr. Naveen Sikka, M.d, M.D
Internal Medicine — Payments: $96,322
Internal Medicine $96,322
Dr. Sibi Thomas, D.o, D.O
Internal Medicine — Payments: $75,591
Internal Medicine $75,591
Stephanie Berg, Md, MD
Internal Medicine — Payments: $42,134
Internal Medicine $42,134
John Treer, Md, MD
Internal Medicine — Payments: $11,539
Internal Medicine $11,539